XUL-33304-42894
2 vaccinations
4 coded responses
21 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 293 / SC
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Dose 1 — Pfizer-BioNTech
-
2021-03-03
Registered in v-safe
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-08
- 2021-03-09
- 2021-03-16
-
2021-03-23
Dose 2 — Pfizer-BioNTech
- 2021-03-23
-
2021-03-24
Survey response — days 1–6 daily, dose 2MedDRA: Rhinitis — Feeling: Good · Site: PainMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-26
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue — Feeling: Good · Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-05-04
-
2021-06-22
Survey response — 3 month, dose 2MedDRA: Chest discomfort, Inflammation, Office visit — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-06-22
Report sent to call center — 3 month, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-06-28
-
2021-08-23
Call successfulParticipant prefers to complete VAERS report online
- 2021-09-21
-
2022-03-23
Survey response — 12 month, dose 2MedDRA: Asthenia, Blood glucose increased, Fatigue, Nephrolithiasis — Feeling: GoodMedDRA releases: 2024-11 · check-in answers available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-03-23 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-22 | Successful 2021-08-23 |
Participant prefers to complete VAERS report online |
Free text
Release 6
Systemic reaction (other): Rhinitis
Systemic reaction (other): Mild fatigue, but did not prevent my session of cardiac rehab today.
Release 9
Symptoms: Chest pressure with increasing severity. Went to ER, checked negative for heart attack, diagnosed with pericarditis, stayed overnight to be observed. With meds, inflammation has subsided. Remain on anti-inflammatory until August cardiologist visit. cut off by CDC
Healthcare visit (other): Follow-up with primary care physician and cardio NP for EKG and screening.
Release 11
Symptoms: Fatigue, low energy level. Elevated BG levels (A1c). Two small kidney stones (neither has passed or caused any pain).
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Blood glucose increased | · | · | ✓ |
| SD | Chest discomfort | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Nephrolithiasis | · | · | ✓ |
| SD | Office visit | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Rhinitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release